Long-Term Outcomes and Treatment Patterns in Waldenström Macroglobulinemia Patients Who Discontinue Bruton Tyrosine Kinase Inhibitor (BTKi) Therapy

Authors

Karan L Chohan
Lorenzo Gensini
Sherif Seif
Xiaowen Sun
Lei Feng
Melody R Becnel
Mahmoud M Gaballa
Hans C Lee
Oren Pasvolsky
Krina K Patel
J Christine Ye
Donna M Weber
Robert Z Orlowski
Sheeba K Thomas

Language

English

Publication Date

12-3-2025

Journal

Blood Cancer Journal

DOI

10.1038/s41408-025-01415-5

PMID

41340003

PMCID

PMC12675605

PubMedCentral® Posted Date

12-3-2025

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Recommended Citation

Chohan, Karan L; Gensini, Lorenzo; Seif, Sherif; et al., "Long-Term Outcomes and Treatment Patterns in Waldenström Macroglobulinemia Patients Who Discontinue Bruton Tyrosine Kinase Inhibitor (BTKi) Therapy" (2025). Faculty, Staff and Student Publications. 6377.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/6377